SD Guthrie International (SDO) is working with University Kebangsaan Malaysia (UKM) to conduct a two years clinical trial on the therapeutic approach of tocotrienols for the treatment of non-alcoholic fatty liver disease (NAFLD). This represents the very first collaboration between SDO and UKM in the medical field involving a commutable disease called the NAFLD.